A total of 29 (2.9%) subjects had anti-PT IgG concentrations ≥100 IU/ml, indicating the recent onset of infection, and 114 (11.4%) subjects had anti-PT-IgG antibodies concentrations ≥40 IU/ml, indicating a recent infection within a few years. This evidence concerns the gene F2 and infection.